Add BrightSurf on Google Email

Search results for “Virus”

1,000+ results for "Virus"

NIH scientists identify protective role for antibodies in Ebola vaccine study

Researchers at NIH and OHSU found that an experimental Ebola vaccine elicits antibodies that protect nonhuman primates from Ebola virus infection. The study's results showed that antibodies induced by the vaccine appeared to be critical to protecting the animals, while immune cells had a minimal role.

SourceNIH/National Institute of Allergy and Infectious Diseases·JournalProceedings of the National Academy of Sciences·DateJan 14, 2013

Virus caught in the act of infecting a cell

Researchers have observed the detailed changes in a virus's structure as it infects an E. coli bacterium, providing new insights into the viral infection process. The study reveals that the virus extends its ultra-thin fibers to find an optimal site for infection and ejects its genetic material through the host cell membrane.

SourceUniversity of Texas at Austin·JournalScience·DateJan 10, 2013

PLOS Pathogens additional press release -- Jan. 10, 2013

Researchers developed methods to synthesize and change the Schmallenberg virus genome, identifying a gene that protects the virus against the immune response. The study found that viruses missing this gene caused less sickness in mice, suggesting potential for new vaccines.

SourcePLOS·JournalPLOS Pathogens·DateJan 10, 2013
AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

Ebola virus uses a protein decoy to subvert the host immune response

Researchers discovered a mechanism by which Ebola virus alters and evades the immune response of its infected host. The secreted protein can selectively drive induction of antibody responses to itself while competing for antibodies to the viral surface protein, enabling repeated or sustained infection.

SourcePLOS·JournalPLOS Pathogens·DateDec 13, 2012

Genetic sleuthing uncovers deadly new virus in Africa

A new viral outbreak in Africa has been linked to the Bas-Congo virus, a previously unknown microbe that causes deadly acute hemorrhagic fever. Genetic analysis reveals the virus is distinct from other rhabdoviruses, including those causing rabies.

SourceUniversity of California - San Francisco·JournalPLOS Pathogens·DateSep 27, 2012
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Scripps Research scientists reveal how deadly virus silences immune system

Scientists at Scripps Research Institute have determined the structure of a critical protein from the Marburg virus, which blocks the human immune system. The breakthrough provides a major step forward in understanding how the deadly virus works and may be useful in developing potential treatments for those infected.

SourceScripps Research Institute·JournalPLOS Pathogens·DateSep 13, 2012

Reconstructed 1918 influenza virus has yielded key insights, scientists say

The reconstructed 1918 influenza virus has provided key insights into how to prevent and control future pandemics. By studying the virus's structure and evolution, researchers have identified potential targets for universal influenza vaccines that can protect against multiple viruses.

SourceNIH/National Institute of Allergy and Infectious Diseases·JournalmBio·DateSep 11, 2012

Field guide to the Epstein-Barr virus charts viral paths toward cancer

Researchers created the most comprehensive study of Epstein-Barr virus genome interactions with its human host. The EBV atlas describes over 60 human transcription factors and highlights the extensive coevolution of the virus, pointing toward possible targets for future cancer and anti-viral drugs.

SourceThe Wistar Institute·JournalCell Host & Microbe·DateAug 23, 2012

Scientists report successful vaccine developed against deadly Nipah virus

Researchers successfully developed a highly effective vaccine against the deadly Nipah virus, which has shown complete protection in African green monkeys with no evidence of disease. The vaccine, known as Hendra-sG, is a recombinant piece of the virus produced in the laboratory and can be used safely for human treatment.

SourceHenry M. Jackson Foundation for the Advancement of Military Medicine·JournalScience Translational Medicine·DateAug 8, 2012
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Griffith University tackles deadly Hendra virus

Researchers at Griffith University are on the brink of an effective human treatment for the deadly Hendra virus, which has killed over 200 people in South East Asia. The therapy attacks the virus by turning off a vital gene and is highly effective in very low doses.

SourceGriffith University·DateJun 3, 2012

Hepatitis C 'switch' offers target for new drug research

Scientists have identified a highly conserved 'switch' in the Hepatitis C virus that can be targeted by custom-designed drugs to lock it into an inactive state. This discovery offers a promising approach to treating the virus, which affects over 170 million people worldwide.

SourceUniversity of Warwick·JournalNucleic Acids Research·DateMay 31, 2012
Sony Alpha a7 IV (Body Only)

Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.

Researchers identify Achilles heel of dengue virus, target for future vaccines

Scientists have pinpointed the region on dengue virus that humans target with their immune system, challenging current vaccine research. The discovery reveals human antibodies bind to a complex structure on assembled dengue viruses, not small fragments as previously thought.

SourceUniversity of North Carolina Health Care·JournalProceedings of the National Academy of Sciences·DateApr 11, 2012

Dengue virus turns on mosquito genes that make them hungrier

Researchers found that dengue virus infection of mosquito salivary glands triggered genes involved in immune response, feeding behavior, and odor sensing. This may facilitate the spread of dengue fever to humans by making mosquitoes more efficient at finding and feeding on hosts.

SourceJohns Hopkins Bloomberg School of Public Health·JournalPLOS Pathogens·DateMar 29, 2012

NIH grantees find dengue affects genes, function of mosquito salivary glands

A recent study found that dengue virus infection triggers changes in the activity of genes and functions of mosquito salivary glands, which may lead to greater virus transmission. The researchers also identified three salivary gland genes that modulate dengue virus infection and two olfactory genes that help control mosquito behavior.

SourceNIH/National Institute of Allergy and Infectious Diseases·JournalPLOS Pathogens·DateMar 29, 2012
Kestrel 3000 Pocket Weather Meter

Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.

Computer simulations help explain why HIV cure remains elusive

A new study suggests that even with a small initial virus population, HIV rapidly evolves to evade immune defenses and treatments due to mutation, recombination, and random genetic changes. This findings sheds light on the difficulty in developing an HIV cure and highlights the need for novel strategies to control the virus.

SourceGenetics Society of America·JournalGenetics·DateMar 15, 2012

Diagnostics for viruses a step closer to reality

Scientists at the University of Leeds create a biosensor technology that can detect Adenovirus viruses, identify individual strains, and count virus particles. This breakthrough could lead to faster, simpler, and less costly testing for viruses, ultimately benefiting patients.

SourceUniversity of Leeds·JournalBiosensors and Bioelectronics·DateFeb 14, 2012

New research reveals how protein protects cells from HIV infection

Researchers have discovered a mechanism by which the immune system tries to halt HIV's spread, focusing on a protein called SAMHD1 that protects cells from viral hijacking. By understanding this mechanism, scientists may find new ways to stop or slow the virus' ability to infect.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalNature Immunology·DateFeb 12, 2012

Viruses con bacteria into working for them

Researchers discovered that certain ocean bacteria are tricked into using their own machinery to activate genes carried by viruses. The viruses inject DNA into stressed bacteria, which then support the virus' replication cycle. This co-evolutionary relationship reveals a sophisticated mechanism of gene regulation and exploitation.

SourceMassachusetts Institute of Technology, Department of Civil and Environmental Engineering·JournalCurrent Biology·DateJan 26, 2012
Apple MacBook Pro 14-inch (M4 Pro)

Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.

Study details how dengue infection hits harder the second time around

Researchers found that prior immune response to one serotype can influence interaction with virus subtypes in a subsequent infection, increasing risk of severe disease. The study provides new insights into the complex interplay between viral genetics and immune system response.

SourceUniversity of California - Berkeley·JournalScience Translational Medicine·DateDec 21, 2011

Polio still a threat to public health

A Tel Aviv University researcher warns that live virus polio vaccine evolution can continue to threaten global eradication efforts. The expert recommends maintaining herd immunity, environmental surveillance, and switching to inactivated vaccines.

SourceAmerican Friends of Tel Aviv University·JournalPLOS ONE·DateNov 7, 2011

Researchers discover why measles spreads so quickly

Researchers discovered measles virus exits host via nectin-4, a biomarker for certain types of cancer. This finding opens up promising new approaches for targeted cancer therapy.

SourceInstitut national de la recherche scientifique - INRS·JournalNature·DateNov 4, 2011

Why is the measles virus so contagious?

The measles virus spreads quickly due to its use of the trachea receptor nectine-4, allowing it to contaminate individuals through airborne transmission. This discovery also reveals a potential link between the measles virus and certain cancers, offering new prospects for cancer treatment.

SourceINSERM (Institut national de la santé et de la recherche médicale)·JournalNature·DateNov 4, 2011
Celestron NexStar 8SE Computerized Telescope

Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.

New oncolytic virus shows improved effectiveness in preclinical testing

A new fourth-generation oncolytic virus has shown greater effectiveness against human brain cancer, improving survival by 50% compared to previous versions. The virus is engineered to replicate in cells expressing nestin, a marker for neuronal stem cells and glioblastoma.

SourceOhio State University Wexner Medical Center·JournalMolecular Therapy·DateOct 27, 2011

Surprises of the measles virus structure

A new three-dimensional model of measles virus helps explain unaccounted observations in its life cycle. The study found matrix protein forms helical tubes around the viral genome and nucleocapsid, regulating replication and genome movement.

SourceUniversity of Helsinki·JournalProceedings of the National Academy of Sciences·DateOct 24, 2011
Apple AirPods Pro (2nd Generation, USB-C)

Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.

Scientists report major advance in the treatment of Hendra virus

A collaborative research team has developed an effective therapy against Hendra virus, giving an anti-virus human monoclonal antibody therapy after exposure protected animals from lethal disease. The study demonstrates promising results and offers a real potential treatment for Hendra virus infection in people.

SourceBoston University School of Medicine·JournalScience Translational Medicine·DateOct 19, 2011

Scientists report major advance in human antibody therapy against deadly Hendra virus

A neutralizing human monoclonal antibody, m102.4, has been developed to protect against Hendra virus infection, showing promise as a potential treatment for severe illness and death in humans. The antibody attacks a critical component of the virus, preventing its infection of cells.

SourceHenry M. Jackson Foundation for the Advancement of Military Medicine·JournalScience Translational Medicine·DateOct 19, 2011

New threat closes in on iconic Galápagos wildlife

A species of mosquito capable of transmitting West Nile virus has been found on Galapagos Islands, posing a significant risk to the archipelago's unique wildlife. Strict insect control measures and further research are recommended to prevent the disease from reaching the islands.

SourceUniversity of Leeds·JournalAmerican Journal of Tropical Medicine and Hygiene·DateSep 16, 2011

Breakthrough opens new avenues for hep C vaccine

Researchers have identified two weak points in the hepatitis C virus that could be targeted by a new vaccine. The discovery uses next-generation deep sequencing and computer analytics to track changes in the virus after infection, revealing opportunities for effective vaccine development.

SourceUniversity of New South Wales·JournalPLOS Pathogens·DateSep 13, 2011
Fluke 87V Industrial Digital Multimeter

Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.

Cell receptor could allow measles virus to target tumors

Researchers discovered that measles virus can target tumors through the PVRL4 receptor, a marker found on lung, breast, colon, and ovarian cancer cells. This approach could be used to fight various types of cancer, with ongoing experiments testing its effectiveness in mouse tumor models.

SourcePLOS·JournalPLOS Pathogens·DateAug 25, 2011

Scientists identify point of entry for deadly Ebola virus

Researchers have identified a protein used by Ebola virus to gain entry into cells and begin replicating, providing a new target for antiviral drugs. This discovery may lead to the development of more stable and effective treatments for Ebola hemorrhagic fever (EHF), currently caused by one of the deadliest known viruses affecting humans.

SourceWhitehead Institute for Biomedical Research·JournalNature·DateAug 24, 2011
GoPro HERO13 Black

GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.

The ignored virus that causes liver cancer

Research suggests Hepatitis G virus may cause liver damage and cancer, contrary to FDA's initial declaration in 1997. A review of scientific literature shows the virus is prevalent globally, linked to hepatitis, cirrhosis, and hepatocellular carcinoma.

SourceInderscience Publishers·JournalInternational Journal of Immunological Studies·DateAug 22, 2011

Researchers on the trail of a treatment for cancer of the immune system

Researchers have discovered a potential treatment for cancer of the immune system, targeting the Epstein Barr virus receptor EB12. The discovery was made by mapping the bio-antenna molecule and creating a blueprint of a tiny molecule that can bind to the B cell EB12 receptor, blocking its activation.

SourceUniversity of Copenhagen·JournalJournal of Biological Chemistry·DateAug 19, 2011

Veterinary researcher receives prestigious grant to study swine disease

Veterinary researcher Scott Kenney received a prestigious USDA grant to investigate the molecular mechanisms of pathogenesis behind porcine reproductive and respiratory syndrome virus. The two-year grant aims to better understand how the virus causes reproductive failure in sows and respiratory diseases in piglets.

SourceVirginia Tech·DateAug 18, 2011

Could the Spanish flu devastate us again?

Researchers at Tel Aviv University have developed a unique computational method to analyze the H1N1 virus, identifying key mutation strategies that led to the 2009 pandemic. This method reveals crucial differences between the pandemic strain and common seasonal H1N1 strains, shedding light on potential vaccine development.

SourceAmerican Friends of Tel Aviv University·JournalProceedings of the National Academy of Sciences·DateAug 15, 2011

Newly discovered antibody recognizes many strains of flu virus

A newly discovered human antibody recognized multiple strains of the flu virus, providing a promising lead for developing a longer-lasting vaccine. The antibody, dubbed CH65, binds tightly to the receptor pocket on the influenza virus, making it less affected by mutations.

SourceHoward Hughes Medical Institute·JournalProceedings of the National Academy of Sciences·DateAug 8, 2011
Davis Instruments Vantage Pro2 Weather Station

Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.

Catching the West Nile virus in action

Researchers track both clinical cases of West Nile Virus and infected mosquito populations to identify 'danger zones' and predict outbreaks. They also analyze the virus's genetic types, dynamics, and mobility to better understand its migration patterns.

SourceAmerican Friends of Tel Aviv University·JournalEurosurveillance·DateJul 25, 2011

UCSF confirms first adenovirus to jump between monkeys and humans

A novel virus spread through a California monkey colony in late 2009, infecting over a third of the monkeys and causing devastating respiratory illness. The virus also infected two human researchers and family members, demonstrating its ability to jump between species.

SourceUniversity of California - San Francisco·JournalPLOS Pathogens·DateJul 14, 2011

Variation in susceptibility to a virus is the key to understanding infection biology

Researchers created four mathematical models of virus infection and tested them against laboratory data. The study found that variation in host susceptibility enhances the prevalence of mixed-genotype micro-parasite infections. The findings improve our understanding of how virus particles interact with each other and the host animal du...

SourcePLOS·JournalPLOS Computational Biology·DateJun 30, 2011

Will new drugs block hepatitis C virus in its tracks?

Researchers at the University of Leeds have discovered a powerful way to suppress hepatitis C by targeting different parts of the virus. Two prototype small molecule drugs, p7 inhibitors, attack the virus in distinct ways, suggesting they could be used together with 'direct-acting' drugs for more effective treatment.

SourceUniversity of Leeds·JournalHepatology·DateJun 28, 2011
Sky-Watcher EQ6-R Pro Equatorial Mount

Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.

New study reveals how the immune system responds to hepatitis A virus

A recent study reveals that hepatitis A virus (HAV) evades the innate immune response more effectively than hepatitis C virus (HCV), which causes chronic infections. The research provides critical insights into the nature of HCV's persistence and highlights the importance of understanding how the body responds to these viruses.

SourceTexas Biomedical Research Institute·JournalProceedings of the National Academy of Sciences·DateJun 20, 2011

Discovery of canine hepatitis C virus opens up new doors for research on deadly human pathogen

Researchers have identified a novel hepatitis C-like virus in dogs, providing new insights into the origins of the human disease. The discovery offers renewed hope for developing a model system to study HCV's mechanisms and may lead to the development of drugs and vaccines.

SourceColumbia University's Mailman School of Public Health·JournalProceedings of the National Academy of Sciences·DateMay 23, 2011

Vaccine protects from deadly Hendra virus

A new experimental vaccine has shown promising results in protecting horses against the deadly Hendra virus, according to CSIRO scientists. The vaccine's successful development could help prevent the spread of the disease from flying foxes to horses and ultimately to people.

SourceCSIRO Australia·DateMay 16, 2011
Apple iPad Pro 11-inch (M4)

Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.

Insight into HIV immunity may lead to vaccine

Researchers found that HIV evolves to evade ADCC antibodies, but these antibodies can force the virus to become weaker. This study suggests that inducing ADCC responses through a vaccine could help prevent HIV infection.

SourceUniversity of Melbourne·JournalProceedings of the National Academy of Sciences·DateMay 6, 2011

Anatomy of an outbreak

Scientists have identified a single amino acid change in the chikungunya virus' exterior protein that enables it to infect Aedes albopictus mosquitoes, allowing for rapid spread across India and Southeast Asia. The discovery sheds light on why outbreaks occurred despite previous strains being present in the region.

SourceUniversity of Texas Medical Branch at Galveston·JournalProceedings of the National Academy of Sciences·DateMay 5, 2011